Expanding the donor pool: When to approve HCV + living liver and kidney donor candidates?

View Archive

After participating in this webinar, the attendee will be able to:

1. Be knowledgeable of background data regarding hepatitis C (HCV) in solid organ transplant
2. Describe relevant considerations in the assessment of potential living donors with active or prior HCV infection which may impact donor and recipient outcomes
3. Appreciate a framework for the screening and evaluation of such donors
4. Describe waitlist management and ethical considerations

Speakers:

• Cameron Wolfe, MD, MBBS(Hons), MPH, FIDSA • Associate Professor of Medicine, Infectious Disease, Duke University Medical Center, Durham, NC
• Whitney Jackson, MD • Assistant Professor, Medicine-Gastroenterology, University of Colorado Medicine, Aurora, CO
• Roy Bloom, MD • Professor of Medicine, University of Pennsylvania Hospital, Philadelphia, PA

Moderator:

• AnnMarie Liapakis, MD • Associate Professor of Medicine, Medical Director Living Donor Liver Transplant, Yale New Haven Transplantation Center, New Haven, CT